official notice
decision of a delegate of the commissioner of patents
Application : No.675414 in the name of Bausch & Lomb Incorporated.
Title: Method and Composition for Cleaning and Disinfecting Contact Lenses.
Action: Application by Allergan Inc. for an extension of time under subsection 223(2) to file a notice of opposition.
Decision: Issued .
Abstract
Allergan’s attorney was watching for acceptance of this divisional application and received
verbal instructions to oppose it before acceptance. The attorney’s interpretation of regulation 5.3(1) in conjunction with his failure to ensure he was reminded about the deadline for filing a notice of opposition resulted in him not complying with Allergan’s instructions.
The relative interests of the parties and the public interest do not favour either granting or refusing the extension of time. Allergan considers there is no subject matter in either the parent or divisional application which is not of interest to it. The decision on the opposition to the grant of a patent on the parent application has not been issued. It seems more likely than not that Allergan is pursuing a serious opposition against the divisional application. There was no undue delay. Discretion exercised in Allergan’s favour and the time to file a notice of opposition extended. Allergan given notice under regulation 22.14 about serving and filing the statement of grounds and particulars.
The finding that Allergan intended to file a notice of opposition depended on a statement made by attorney at the hearing. The applicant did not say it would not have attended the hearing if this statement had been made earlier. No award of costs.
patents act 1990
decision of a delegate of the commissioner of patents
Re:Application no.675414 by Bausch & Lomb Incorporated and an application by Allergan Inc. for an extension of time under subsection 223(2) to file a notice of opposition.
background
Application no.30439/92 by Bausch & Lomb Incorporated (Bausch) is a further application from application no.49989/90 (now no.628926). The application was advertised as accepted under no.675414 on 6 February 1997 and thus any notice of any opposition was due to be filed by 6 May 1997. On 6 May 1997 Alcon Laboratories Inc (Alcon) filed a notice of opposition to the grant of a patent on the application.
On 12 May 1997 Allergan Inc (Allergan) filed a notice of opposition to the grant of a patent on the application which was accompanied by an application for an extension of time under section 223(2). Allergan filed a statutory declaration in support of its extension of time on 16 May 1997.
A copy of the application was sent to Bausch’s attorneys on 26 May 1997 and it objected to the extension of time. The matter was set for hearing in Canberra on 16 July 1997 and both parties appeared by telephone. Bausch was represented by Dr C Bodkin, patent attorney, of Spruson & Ferguson and Allergan was represented by Dr P Stearne, patent attorney, of Davies Collison Cave. Mr J Siely, patent attorney, of Davies…
Keep reading for free
Create a free CaseChat account to read Bausch and Lomb Incorpoprated v Allergan Inc and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1997] APO 45
- Decision Date
CaseChat Overview and Summary
In reaching its decision, the court considered the nature of the error or omission, the intent of Allergan to oppose the application, the relative interests of the parties and the public, and whether there was undue delay in filing the application for extension of time. The court found that Allergan intended to oppose the application based on a statement made by their patent attorney at the hearing. It also found that the relative interests of the parties and the public interest did not favour either granting or refusing the extension of time. The court concluded that there was no undue delay, as the period of delay was approximately two months.
The court exercised its discretion in favour of Allergan and granted the extension of time, allowing Allergan until 12 May 1997 to file a notice of opposition. The court also gave Allergan notice under regulation 22.14 about serving and filing a statement of grounds and particulars. The court decided not to award costs to either party, as it found that Bausch & Lomb's objection to the extension of time was not frivolous.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi